The Commercial Determinants of Health: Investor Action on Health
This study, supported by The Health Foundation and led by Niamh O’Sullivan and Simon Bishop in Nottingham University Business School,...
Commercial
ImmunityBio to Host Key Opinion Leader and Investor Meeting to Provide Updates on Clinical Programs and ANKTIVA Commercial Launch
CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced details about its Investor Day program to...
